This study evaluates lymphedema after undergoing immediate lymphatic reconstruction at the time of breast and axillary surgery for patients with breast cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07227467.
Locations matching your search criteria
United States
Illinois
Chicago
University of Chicago Comprehensive Cancer CenterStatus: Active
Contact: Summer E. Hanson
Phone: 773-702-6302
PRIMARY OBJECTIVES:
I. Determine the efficacy of immediate lymphatic reconstruction (ILR) based on objective circumference, volume, and bioimpedence spectroscopy measurements of affected and unaffected limbs of women before and after surgery.
II. Determine the impact of ILR on validated patient reported outcome tools including the lymphedema life impact scale and upper extremity range of motion and shoulder scores between affected and unaffected limbs before and after surgery.
III. Characterize the axillary microbiome in limbs that have been treated with ILR compared to those that were unaffected before and after surgery.
OUTLINE: This is an observational study.
Patients undergo limb circumference measurements, range of motion assessments, bioimpedance spectroscopy, axillary skin swabs and complete surveys on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Chicago Comprehensive Cancer Center
Principal InvestigatorSummer E. Hanson
